F · Healthcare

SELLAS Life Sciences Group Inc (RXK3)

Biotechnology

SELLAS Life Sciences Group Inc (RXK3) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $762.33M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for RXK3

Market cap

$762.33M

P/E ratio

18.00

Gross profit (TTM)

$900,000

Net margin

0.0%

SELLAS Life Sciences Group Inc (RXK3) — FAQ

What is SELLAS Life Sciences Group Inc's market cap?

SELLAS Life Sciences Group Inc (RXK3) has a reported market cap of $762.33M (data as of 2026-03-30).

What is RXK3's P/E ratio?

The price-to-earnings (P/E) ratio for SELLAS Life Sciences Group Inc (RXK3) is 18.00 (data as of 2026-03-30).

Does SELLAS Life Sciences Group Inc pay a dividend?

Dividend yield is not available in the current snapshot for SELLAS Life Sciences Group Inc (RXK3). Check the MyAverix Finance app for the latest dividend data.

What sector is SELLAS Life Sciences Group Inc in?

SELLAS Life Sciences Group Inc (RXK3) is classified in the Healthcare sector (Biotechnology industry).

What exchange is RXK3 listed on?

RXK3 is listed on F.

What is SELLAS Life Sciences Group Inc's net margin?

SELLAS Life Sciences Group Inc (RXK3) reports a net margin of 0.0% (data as of 2026-03-30).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Aimed Bio (0009K0) Celltrion (068270) Rznomics (476830)